Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / *W EXP 12/31/202
-
Total 13F shares
-
3,327,605
-
Share change
-
-239,200
-
Total reported value
-
$2,942,800
-
Price per share
-
$0.88
-
Number of holders
-
16
-
Value change
-
-$458,523
-
Number of buys
-
6
-
Number of sells
-
13
Institutional Holders of EFFECTOR THERAPEUTICS INC - *W EXP 12/31/202 (EFTRW) as of Q4 2021
As of 31 Dec 2021,
EFFECTOR THERAPEUTICS INC - *W EXP 12/31/202 (EFTRW) was held by
16 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,327,605 shares.
The largest 10 holders included
ARISTEIA CAPITAL LLC, GOLDMAN SACHS GROUP INC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, MMCAP International Inc. SPC, PURA VIDA INVESTMENTS, LLC, CVI Holdings, LLC, Integrity Capital Management (HK) Ltd, WOLVERINE ASSET MANAGEMENT LLC, CREDIT SUISSE AG/, and CSS LLC/IL.
This page lists
16
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.